Healthcare
PRF Technologies Issues Letter to Shareholders Highlighting Strengthened Financial Position and Building Momentum Across Its Biotechnology and AI-Driven Energy Platforms
Interim CEO Efraim Cohen-Arazi Details $10 Million in New Capital, LayerBio's Preparations for the Planned Phase 2 Clinical Trial of OcuRing™-K, and DeepSolar's Advance Toward Commercial LaunchTEL AVIV, Israel, July 27, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF”, “PRF Technologies” or the “Company”) today issued a Letter to Shareholders from Efraim Cohen-Arazi, Interim Chief Executive Officer. First-Half 2026 and Recent Highlights: Raised $10 million through the Company
About this update from Prf Technologies Ltd.
Interim CEO Efraim Cohen-Arazi Details $10 Million in New Capital, LayerBio's Preparations for the Planned Phase 2 Clinical Trial of OcuRing™-K, and DeepSolar's Advance Toward Commercial Launch TEL AVIV, Israel, July 27, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) ("PRF", "PRF Technologies" or the "Company") today issued a Letter to Shareholders from Efraim Cohen-Arazi, Interim Chief Executive Officer. First-Half 2026 and Recent Highlights: Dear Fellow Shareholders, As we move through the second half of 2026, I am excited to share an update on PRF Technologies' progress and the strategic priorities that are expected to guide the Company in the months ahead. Simply put: PRF today is stronger, better capitalized and moving with more momentum than it was just six months ago. During the first half of 2026, we achieved a transformative milestone by significantly strengthening our financial position. We believe that this accomplishment provides PRF with increased strategic flexibility and positions us to execute our long-term growth strategy from a position of strength. Strengthening Our Financial Foundation On May 28, 2026, PRF raised $10 million through its equity line facility. This financing substantially strengthened our balance sheet and provides the resources necessary to accelerate our existing businesses while pursuing additional strategic growth opportunities. We believe that our strengthened financial position allows us to focus on disciplined execution while maintaining the flexibility to capitalize on attractive opportunities as they arise. Executing a Disciplined Growth Strategy Our strategy remains centered on creating long-term shareholder value through disciplined capital allocation focused on the development of innovative technology businesses. While we remain committed to advancing our existing biotechnology and renewable energy platforms, we are also evaluating strategic opportunities that we believe have the potential to accelerate growth and enhance shareholder value. These opportunities may include strategic partnerships, licensing arrangements, investments and selective acquisitions of complementary technologies or companies that align with our long-term vision. We intend to pursue such opportunities with financial discipline and only where they strengthen our strategic position and have the potential to create sustaina...
View stock analysis, news, and events for Prf Technologies Ltd.